Answers are grounded in this paper and cite their sources.
Treatment with this type of active tPEMF was not superior to sham in patients with TRD. This is in contrast to a previous study using a similar design and power calculation, but a higher magnetic field strength, that reported improvement of depression after treatment with tPEMF compared to sham. An important limitation of our study was the fact that no different dosing regimens were tried.
No takes yet. Share an insight, caveat, or question.
Belkum et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: